Connect to share and comment
Feb 7 (Reuters) - Medical technology company Lifeline Scientific Inc said it expects to report a lower pretax profit for 2012, partly due to a decrease in gross margins and certain legal costs.
The lower margins resulted from changes in product mix, the company said in a statement.
However, it estimated full-year revenue to be higher.
The company reported a profit before income tax of $2.4 million and revenue of $25.4 million in 2011.
The company also said it incurred significant legal expenses related to a lawsuit brought in June 2011 against a competitor and a former vendor.
Shares in the company closed at 195 pence on Wednesday on the London Stock Exchange.